Drug intelligence / Profile preview

heparinoid sodium

Development stage
Unknown
Lead developer
YINO PHARMA
Modality
Small Molecules
Administration
Topical
01

Overview

Heparinoid sodium is a mixture of sulfated glycosaminoglycans (mucopolysaccharides) derived from animal tissues, structurally related to heparin. It is primarily employed in topical dermatological preparations for its anticoagulant, anti-inflammatory, and humectant properties. The drug exerts its therapeutic effects by inhibiting thrombin and Factor Xa, thereby improving microcirculation and reducing blood viscosity, and by inhibiting hyaluronidase to decrease tissue inflammation. Additionally, it enhances the water-holding capacity of the stratum corneum, making it effective for treating xeroderma (dry skin). It is also indicated for the management of hypertrophic scars, keloids, and superficial thrombophlebitis.

Brand names
HirudoidAdryBeselna
Other names
heparinoidmucopolysaccharide polysulfateMPS
02

Targets

F2 (Thrombin)HYAL (Hyaluronidase family (HYAL))ATIII (Antithrombin III)F10 (Factor Xa)

Beyond the preview

Go deeper on heparinoid sodium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on heparinoid sodium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call